Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kratom instrumentalization for severe pain self-treatment resulting in addiction – A case report of acute and chronic subjective effects
Elisabeth Müller, Thomas Hillemacher, Christian P. Müller
Heliyon (2020) Vol. 6, Iss. 7, pp. e04507-e04507
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a cross-sectional investigation
Oliver Grundmann, Charles A. Veltri, Diana Morcos, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 4, pp. 433-444
Closed Access | Times Cited: 31
In vitro and in vivo pharmacology of kratom
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, et al.
Advances in pharmacology (2022), pp. 35-76
Closed Access | Times Cited: 23
Mitragynine (Kratom)—Withdrawal behaviour and cognitive impairments can be ameliorated by an epigenetic mechanism
Suleiman Yunusa, Christian P. Müller, Zurina Hassan
British Journal of Pharmacology (2024) Vol. 181, Iss. 13, pp. 2070-2084
Closed Access | Times Cited: 4
Sex‐Dependent Alcohol Instrumentalization Goals in Non‐Addicted Alcohol Consumers versus Patients with Alcohol Use Disorder: Longitudinal Change and Outcome Prediction
Christian P. Müller, Christiane Mühle, Johannes Kornhuber, et al.
Alcoholism Clinical and Experimental Research (2021) Vol. 45, Iss. 3, pp. 577-586
Open Access | Times Cited: 25
Mitragyna speciosa (Kratom) poisoning: Findings from ten cases
David Peřan, Michael P. Stern, Petr Černohorský, et al.
Toxicon (2023) Vol. 225, pp. 107054-107054
Closed Access | Times Cited: 10
Diagnostic Ambiguities and Underuse of Clinical Assessment Tools: A Systematic Review of Case Reports on Kratom Addiction and Physical Dependence
Kirsten E. Smith, Jeffrey D. Feldman, Destiny Schriefer, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 282-292
Closed Access | Times Cited: 9
Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa)
Chad Hartley, Marilyn N. Bulloch, Scott Penzak
The Journal of Clinical Pharmacology (2021) Vol. 62, Iss. 5, pp. 577-593
Closed Access | Times Cited: 19
Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant
Alessandro Vento, Simone De Persis, Sergio De Filippis, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 18
Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study
Antonio Metastasio, Elisabeth Prevete, Darshan Singh, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 19
Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic – A case report
Elisabeth Müller, Thomas Hillemacher, Christian P. Müller
Heliyon (2021) Vol. 7, Iss. 5, pp. e07039-e07039
Open Access | Times Cited: 16
Cross-reinstatement of mitragynine and morphine place preference in rats
Rima Atria Japarin, Nurul H.M. Yusoff, Zurina Hassan, et al.
Behavioural Brain Research (2020) Vol. 399, pp. 113021-113021
Closed Access | Times Cited: 17
The effects of chronic mitragynine (Kratom) exposure on the EEG in rats
Farah Wahida Suhaimi, Zurina Hassan, Sharif Mahsufi Mansor, et al.
Neuroscience Letters (2021) Vol. 745, pp. 135632-135632
Closed Access | Times Cited: 15
The modulatory effects of alkaloid extracts of Cannabis sativa, Datura stramonium, Nicotiana tabacum and male Carica papaya on neurotransmitter, neurotrophic and neuroinflammatory systems linked to anxiety and depression
Olamide Wilson Fasakin, Ganiyu Oboh, Ayokunle O. Ademosun, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2447-2476
Closed Access | Times Cited: 10
Mitragynine (Kratom)-Induced Cognitive Impairments in Mice Resemble Δ9-THC and Morphine Effects: Reversal by Cannabinoid CB1 Receptor Antagonism
Nurul Iman Ismail, Nur Aimi Zawami Ahmad, Nurul Aiman Mohd Yusof, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 14
Kratom availability in California vape shops
Molly A. Bowdring, Eric C. Leas, Monika Vishwakarma, et al.
Preventive Medicine Reports (2023) Vol. 35, pp. 102380-102380
Open Access | Times Cited: 5
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
Rahimah Hassan, Sreenivasan Sasidharan, Christian P. Müller, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 12
Proteomic analysis reveals brain Rab35 as a potential biomarker of mitragynine withdrawal in rats
Rahimah Hassan, Nurulhasanah Othman, Sharif Mahsufi Mansor, et al.
Brain Research Bulletin (2021) Vol. 172, pp. 139-150
Closed Access | Times Cited: 9
The effect of mitragynine on extracellular activity of brain dopamine and its metabolites
Nurul H.M. Yusoff, Zurina Hassan, Vikneswaran Murugaiyah, et al.
Brain Research Bulletin (2021) Vol. 178, pp. 1-8
Closed Access | Times Cited: 8
Kratom use disorder: a primer for primary care physicians
Destin Groff, Heather L. Stuckey, Carolyn Philpott, et al.
Journal of Addictive Diseases (2021) Vol. 40, Iss. 1, pp. 131-141
Closed Access | Times Cited: 6
The Health Impact of Long-Term Kratom ( Mitragyna Speciosa ) Use in Southern Thailand
Darika Saingam, Darshan Singh, Alan Geater, et al.
Substance Use & Misuse (2023) Vol. 58, Iss. 10, pp. 1212-1225
Closed Access | Times Cited: 2
Kratom (<i>Mitragyna speciosa</i>) Use and Mental Health: A Systematic Review and Multilevel Meta-Analysis
Yuting Yang, Christian P. Müller, Darshan Singh
European Addiction Research (2024) Vol. 30, Iss. 4, pp. 252-274
Closed Access
Kratom: a primer for pain physicians
Trent Emerick, Shravani Durbhakula, Maria R. Eibel, et al.
Current Opinion in Anaesthesiology (2024) Vol. 37, Iss. 5, pp. 575-580
Closed Access
Kratom – vom natürlichen Heilmittel zur Suchtdroge und zurück
Christian P. Müller, Yuting Yang, Darshan Singh, et al.
Der Nervenarzt (2024) Vol. 95, Iss. 9, pp. 824-829
Closed Access
Page 1 - Next Page

Scroll to top